The results showed that TET1 knockdown significantly increased the killing effect of sorafenib on tumor cells (Fig. 2C-F), although TET1 knockdown alone also inhibited the proliferation of HCC cells to a certain degree. The gene discussed is TET1; the disease is hepatocellular carcinoma.